Hyperkalemia

67,960views

Hyperkalemia

Watch later

Watch later

Cerebral vascular disease: Pathology review
Movement disorders: Pathology review
Endocrine system anatomy and physiology
Growth hormone and somatostatin
Pituitary adenoma
Hypopituitarism
Constitutional growth delay
Hypertension
Pharmacokinetics: Drug elimination and clearance
Hyponatremia
Hyponatremia: Clinical
Hypernatremia: Clinical
Hypernatremia
Acute pyelonephritis
Chronic pyelonephritis
Urinary tract infections: Clinical
Urinary tract infections: Pathology review
Lower urinary tract infection
Stroke: Clinical
Ischemic stroke
Intracerebral hemorrhage
Dizziness and vertigo: Clinical
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Clot retraction and fibrinolysis
Cell wall synthesis inhibitors: Cephalosporins
Chronic kidney disease
Chronic kidney disease: Clinical
Normal heart sounds
Abnormal heart sounds
Phosphate, calcium and magnesium homeostasis
Parathyroid conditions and calcium imbalance: Clinical
Hypocalcemia
Hypercalcemia
Hyperkalemia
Hypokalemia
Pulmonary embolism
Deep vein thrombosis
Anatomic and physiologic dead space
Muscular dystrophy
Ventilation-perfusion ratios and V/Q mismatch
Pulmonary shunts
Vaccinations: Clinical
Pediatric ear, nose, and throat conditions: Clinical
Laryngitis
Cell wall synthesis inhibitors: Penicillins
Congenital heart defects: Clinical
Ventricular septal defect
Atrial septal defect
Patent ductus arteriosus
Coarctation of the aorta
Tetralogy of Fallot
Acid-base disturbances: Pathology review
Acid-base map and compensatory mechanisms
The role of the kidney in acid-base balance
Metabolic acidosis
Respiratory acidosis
Metabolic and respiratory acidosis: Clinical
Metabolic alkalosis
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Fever of unknown origin: Clinical
Viral exanthems of childhood: Pathology review
Cerebral palsy
Newborn management: Clinical
Neonatal ICU conditions: Clinical
Neonatal jaundice: Clinical
Pediatric vomiting: Clinical
Developmental milestones: Clinical
Precocious and delayed puberty: Clinical
Seizures: Clinical
Congenital TORCH infections: Pathology review
Kawasaki disease: Clinical
Pediatric infectious rashes: Clinical
Psoriasis
Atopic dermatitis
Eczematous rashes: Clinical
Chronic leukemia
Acute leukemia
Leukemia: Clinical
Immunodeficiencies: Clinical
Non-steroidal anti-inflammatory drugs
Acetaminophen (Paracetamol)
Sexually transmitted infections: Clinical
Gallbladder disorders: Clinical
Gallbladder disorders: Pathology review
Acute cholecystitis
Gallstones
Ascending cholangitis
Chronic cholecystitis
Sciatica
Back pain: Pathology review
Lower back pain: Clinical
Cauda equina syndrome
Spinal cord disorders: Pathology review
Abdominal pain: Clinical
Diarrhea: Clinical
Ulcerative colitis
Crohn disease
Anatomy of the knee joint
Routine prenatal care: Clinical
Burns
Burns: Clinical
Gastrointestinal bleeding: Clinical
Jaundice
Bile secretion and enterohepatic circulation

Transcript

Watch video only

With hyperkalemia, hyper- means over and -kal- refers to potassium, and -emia refers to the blood, so hyperkalemia means higher than normal potassium levels in the blood, generally over 5.5 mEq/L.

Now, total body potassium can essentially be split into two components—intracellular and extracellular potassium, or potassium inside and outside cells, respectively.

The extracellular component includes both the intravascular space, which is the space within the blood and lymphatic vessels and the interstitial space, the space between cells where you typically find fibrous proteins and long chains of carbohydrates which are called glycosaminoglycans.

Now, the vast majority, around 98%, of all of the body’s potassium is intracellular, or inside of the cells.

In fact, the concentration of potassium inside the cells is about 150 mEq/L whereas outside the cells it’s only about 4.5 mEq/L.

Keep in mind that these potassium ions carry a charge, so the difference in concentration also leads to a difference in charge, which establishes an overall electrochemical gradient across the cell membrane. This is called the internal potassium balance.

This balance is maintained by the sodium-potassium pump, which pumps 2 potassium ions in for every 3 sodium ions out, as well as potassium leak channels and inward rectifier channels that are scattered throughout the membrane.

This concentration gradient is extremely important for setting the resting membrane potential of excitable cell membranes, which is needed for normal contraction of smooth, cardiac, and skeletal muscle.

Also, though, in addition to this internal potassium balance, there’s also an external potassium balance, which refers to the potassium you get externally through the diet every day.

On a daily basis the amount of potassium that typically gets taken in usually ranges between 50 mEq/L to 150 mEq/L, which is way higher than the extracellular potassium concentration of 4.5 mEq/L, so your body has to figure out a way to excrete most of what it takes in.

This external balancing act is largely taken care of by the kidneys, where excess potassium is secreted into a renal tubule and excreted in the urine.

Also though, a small amount dietary potassium is also lost via the gastrointestinal tract and sweat.

So, in order for there to be too much potassium in the blood, or hyperkalemia, there are two possibilities.

The first is an external balance shift, which is most often caused by a decrease in sodium excretion in the kidneys, which raises the level of potassium in the blood.

The second is an internal balance shift where potassium moves out of cells, and into the interstitium and blood. One potential cause of an internal potassium balance shift is insulin deficiency.

This is because, after a meal, glucose increases in the blood, and at the same timeinsulin gets released which binds to cells and stimulates uptake of that glucose.

Insulin also increases the activity of the sodium/potassium pump, which pulls potassium into cells.

People with type I diabetes don’t make enough insulin, so when they eat a meal—especially a meal with a lot of potassium—that potassium sits in the blood instead of being taken into cells, and this causes hyperkalemia.

Another cause of an internal potassium balance shift could be an acidosis, which is when the blood becomes too acidic, in other words, there’s a higher concentration of hydrogen ions—which means a lower blood pH.

One way the body can increase the blood pH is by moving hydrogen ions out of the blood and into cells.

To accomplish this, cells use a complex series of multiple ion channels, exchangers, and pumps to exchange hydrogen ions for potassium ions across the cell membrane.

So in order to help compensate for an acidosis, hydrogen ions enter cells and potassium ions leave the cells and enter the blood, which might help with the acidosis, but results in hyperkalemia.

Now, this isn’t always the case for acidosis, though. in respiratory acidosis, potassium levels aren’t affected because CO2 is lipid soluble and freely moves into cells without being exchanged for potassium, therefore no hyperkalemia.

Similarly, when there’s a metabolic acidosis from excess organic acids like lactic acid and ketoacids, protons can enter cells with the organic anion rather than having to get exchanged for potassium ions.

Certain catecholamines can also shift potassium out of cells, and this is via beta-2-adrenergic and alpha-adrenergic receptors on cell membranes. When activated, beta-2-adrenergic receptors stimulate the sodium-potassium pump, which pulls potassium from the blood into cells.

Meanwhile alpha-adrenergic receptors cause a shift of potassium out of cells via calcium-dependent potassium channels.

So, that said, beta-2-adrenergic antagonists, also known as beta blockers, and alpha-adrenergic agonists, both cause a shift in potassium out of the cells and into the blood.

Another important mechanism is hyperosmolarity, which is where there is an increased extracellular osmolarity, relative to the intracellular space. This osmotic gradient pulls water out of cells and into the extracellular space.

Less water in the cells increases the intracellular potassium concentration, which increases potassium’s concentration gradient, and pushes more of it out of the cell and into the interstitium and blood. Cell lysis is yet another cause of hyperkalemia.

Since so much potassium is kept within the cell, when a large number of cells die or lyse, potassium is released into the blood, which causes hyperkalemia.

Examples of large-scale cell lysis are severe burnsrhabdomyolysis or breakdown of skeletal muscle, and tumor lysis as a result of chemotherapy. A final example of internal potassium balance leading to hyperkalemia is exercise. During exercise while the body and the body’s cells are working harder, more cellular ATP, which is the molecular unit of currency, gets consumed.

The depletion of ATP triggers potassium channels on the membrane of muscle cells to open up, which allows potassium to moves down its electrochemical gradient and out of the cell.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoceptors" Fundamental & Clinical Pharmacology (1993)
  6. "Management of Hyperkalemia: An Update for the Internist" The American Journal of Medicine (2015)
  7. "Management of patients with acute hyperkalemia" Canadian Medical Association Journal (2010)